®
Bismillahirrahmanirrahim
SCIENCE
Only 5% of drugs that enter clinical trials
are ultimately approved
due to limitations in pre-clinical testing.
What if we could change that?
Precise data starts with protected samples:
Our reagents, products, and methods have been designed to analyze
organoids, spheroids, and cells directly within their ideal growing environment.
Image: Liver Cancer Spheroids in CellO-M
Our patent-pending technologies transform studies by:
Safeguarding Biospecimens
The technology minimizes sample manipulation and simplifies complex protocols
eliminating stressful transfers, centrifuging, and pipetting.
Preserved 3D Architecture
The delicate 3D structure of cells, organoids, and spheroids are protected
in an elegantly designed environment.
That provides a more complete picture of cellular behavior
by analyzing cells in their native state.
Uncompromised Cellular Integrity
Molecules and structures remain intact,
leading to unparalleled data accuracy and reduced variability.
​
The Result: Streamlined Workflows and Accelerated Research
Reduced Time & Costs by up to 30%
The scientists save valuable time
and resources previously spent on tedious protocols.
​
Confident Studies, Faster Insights
The technology assures reliable data,
streamlines workflows, and accelerates research progress
by significantly reducing the need for repeat experiments (up to 50%).
​
Unlocking the Power of Reliable Data
Identify New Drug Targets
The technology empowers scientists
to gain a clearer picture of biological processes,
paving the way for the discovery of novel drug targets.
Faster Drug Development
The technology ensures the production of reliable data,
which is a key factor for decision-making in drug development.
Reduced Costs & Improved Outcomes
The technology eliminates wasted research from unreliable data,
freeing up crucial resources
for breakthrough drug development and personalized medicine.
​
Cellorama Protocols
Investigation of organoids, spheroids, and cells has never been
this simple and precise with the following protocols:
